Skip to main content

Table 1 Pretreatment subject demographics and baseline characteristics

From: Efficacy of Leuprolide Acetate 1-Month Depot for Central Precocious Puberty (CPP): Growth Outcomes During a Prospective, Longitudinal Study

 

Female Patients

Characteristic

N = 49

Race, n (%)

 

   Caucasian

30 (61.2)

   African American

11 (22.4)

   Asian

0

   Hispanic

8 (16.3)

Age, years

 

   Mean (SD)

7.3 (1.9)

   Range

1.2-9.4

Weight, kg

 

   Mean (SD)

33.6 (9.72)

   Range

13.0-52.2

Height, cm

 

   Mean (SD)

131.6 (14.97)

   Range

84.6-154.7

Height Standardized Score

 

   Mean (SD)

1.5 (1.29)

   Range

-1.4-3.4

Tanner Stage, n (%)

 

   Breast/Genitalia I

1 (2.0)a

II

9 (18.4)

III

25 (51.0)

IV

13 (26.5)

V

1 (2.0)

Growth Velocity, cm/yr

 

   Mean (SD)

10.7 (3.40)

   Range

5.5-21.2

BA, years

 

   Mean (SD)

10.2 (2.13)

   Range

2.5-12.1

BA - CA, years

 

   Mean (SD)

3.0 (0.80)

   Range

1.3-4.5

History of Menstrual Bleeding, n (%)

 

   No

36 (75)

   Yes

12 (25)

  1. aA one year old patient was enrolled in the trial with breast Tanner stage I based on qualifying peak stimulated LH (84.7 IU/L) and E2 (90 pg/mL).